Send me a link:

*Text messaging rates may apply.

 Dow Up 0.17% Nasdaq Up 0.44%

More On NEUN

Quotes

Charts

News & Info

Company

Analyst Coverage

  • Analyst Opinion
  • Analyst Estimates

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

  • Income Statement
  • Balance Sheet
  • Cash Flow

Neurogenesis Inc. (NEUN)

-Other OTC
0.01 Down 0.00(11.11%) Jul 11, 12:11PM EDT
Prev Close:0.01
Open:0.01
Bid:N/A
Ask:N/A
1y Target Est:N/A
Beta:N/A
Next Earnings Date:N/A
Day's Range:0.01 - 0.01
52wk Range:0.01 - 0.01
Volume:40,200
Avg Vol (3m):N/A
Market Cap:162.30K
P/E (ttm):N/A
EPS (ttm):0.00
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):0.17
Ex-Dividend Date:N/A

Analysts

Annual EPS Est () :N/A
Quarterly EPS Est () :N/A
Mean Recommendation*:N/A
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

NeuroGenesis, Inc. engages in the development of a series of products to be used as adjuncts to therapy by the substance-abuse treatment community. Neurotransmitters are chemicals that allow communication to occur in the brain. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback